Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan
- DOI
- 10.1038/s41598-022-04952-2
- Published
- 2022-02-14
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-022-04952-2,
title = {Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan},
author = {Ko Ko and Kazuaki Takahashi and Shintaro Nagashima and Bunthen E and Serge Ouoba and Md Razeen Ashraf Hussain and Tomoyuki Akita and Aya Sugiyama and Takemasa Sakaguchi and Hidetoshi Tahara and Hiroki Ohge and Hideki Ohdan and Tatsuhiko Kubo and Nobuhisa Ishikawa and Toshiro Takafuta and Yoshiki Fujii and Michi Mimori and Fumie Okada and Eisaku Kishita and Kunie Ariyoshi and Masao Kuwabara and Junko Tanaka},
year = {2022},
journal = {Scientific Reports},
doi = {10.1038/s41598-022-04952-2},
url = {https://doi.org/10.1038/s41598-022-04952-2}
}RIS
TY - JOUR TI - Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan AU - Ko Ko AU - Kazuaki Takahashi AU - Shintaro Nagashima AU - Bunthen E AU - Serge Ouoba AU - Md Razeen Ashraf Hussain AU - Tomoyuki Akita AU - Aya Sugiyama AU - Takemasa Sakaguchi AU - Hidetoshi Tahara AU - Hiroki Ohge AU - Hideki Ohdan AU - Tatsuhiko Kubo AU - Nobuhisa Ishikawa AU - Toshiro Takafuta AU - Yoshiki Fujii AU - Michi Mimori AU - Fumie Okada AU - Eisaku Kishita AU - Kunie Ariyoshi AU - Masao Kuwabara AU - Junko Tanaka PY - 2022 JO - Scientific Reports DO - 10.1038/s41598-022-04952-2 UR - https://doi.org/10.1038/s41598-022-04952-2 ER -
APA
Ko, K., Takahashi, K., Nagashima, S., E, B., Ouoba, S., Hussain, M. R. A., Akita, T., Sugiyama, A., Sakaguchi, T., Tahara, H., Ohge, H., Ohdan, H., Kubo, T., Ishikawa, N., Takafuta, T., Fujii, Y., Mimori, M., Okada, F., Kishita, E., Ariyoshi, K., Kuwabara, M., & Tanaka, J. (2022). Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan. Scientific Reports. https://doi.org/10.1038/s41598-022-04952-2
Source records
- crossref · retrieved 2026-09-26T16:15:51.422Z